Sorry, this entry is only available in Polish.
Powiązane
SK&S’ IP team recognised by the Intellectual Asset Management magazine
We are pleased to announce that our IP team won a Gold Laurel in the ranking of the IAM Patent…
07 Jul 2022
Report SK&S | Electronic cigarette
Electronic cigarettes, especially disposable ones, have recently been the subject of public debate, primarily due to the announcement of restrictions…
10 Jun 2024
SK&S advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
25 Apr 2024
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
05 Dec 2023
Legal Alert | Status of the CBD in 2024 – summary
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
27 Feb 2024
SK&S’ IP team recognised by the Intellectual Asset Management magazine
The Intellectual Property law team of Sołtysiński Kawecki & Szlęzak has been awarded a Gold Laurel in Intellectual Asset Management…
29 Jun 2023
SK&S recommended in the Legal500 ranking – 2022
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
12 Apr 2022
Report SK&S | CBD in energy drinks
The hemp industry is not only one of the fastest growing in Poland, but also worldwide. New products made with…
08 Jul 2022
SK&S advised AniCura on partnership with veterinary clinic “Wróblewscy”
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
15 Mar 2023
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
Legal Alert | New “Blue Guide” published!
At the end of June, the European Commission (EC) published an updated “Blue Guide”, which, first published in 2000, has…
27 Jul 2022
ANTI-CRISIS SHIELD – regulatory changes
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
02 Apr 2020
SK&S recommended in the Legal500 ranking – 2024
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
28 Mar 2024
Legal Alert | European Commission proposes more changes for medical devices
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
29 Feb 2024
Medicinal products, medical devices, biocidal products in the context of the COVID-19 epidemic
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
25 Mar 2020